Dr. Milan Matthew Lombardi, MD

Dr. Lombardi practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Lombardi's NPI, 1003083247, was assigned on May 15, 2008. Dr. Lombardi graduated from Weill Cornell Medicine in 2008. Dr. Lombardi holds Florida license ME116665.

Dr. Lombardi's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Lombardi's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Lombardi to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lombardi practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lombardi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lombardi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lombardi's licenses on file in 4 states: Florida, Missouri, California and New York.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and minor head injury among the conditions Dr. Lombardi treats.

CMS data shows 2,173 Medicare services from Dr. Lombardi across 23 procedure codes in 2024, for 435 Medicare patients. Medicare paid $237,453 for them. Every service was in an office.

CMS counts 435 Medicare patients who saw Dr. Lombardi in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lombardi's median patient age at 74, with 43% women.

In 2024, Dr. Lombardi wrote 486 Medicare Part D claims for 229 patients. 100% of them were for generic drugs. CMS names the drug for 422 of them, across 11 drugs with 11 or more claims each, at $9,164 in total drug cost. In 2023, CMS named 311 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lombardi for performance year 2024, reported as part of a group. Dr. Lombardi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 570 procedures of removal of skin lesions by Dr. Lombardi, more than 88% of the clinicians it reports for that procedure.

CMS Open Payments shows 27 general payments to Dr. Lombardi from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $503.

Dmand AI lists 1 award for Dr. Lombardi, most recently CMS Stage 1 EHR in 2013.

Dr. Lombardi graduated from Weill Cornell Medicine in 2008.

Dr. Lombardi is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.